Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome

Completed

Conditions studied: Leukemia, Myelodysplastic Syndromes

In brief

RATIONALE: Diagnostic procedures may improve the ability to detect residual disease. PURPOSE: Clinical trial to detect the presence of residual disease in children who are receiving therapy for acute myeloid leukemia or myelodysplastic syndrome.

Key facts

Study ID
NCT00003790
Run by
Children's Oncology Group
People needed
496
Starts
1995-02-01
Expected to finish
2006-09-01
Last updated by the study team
2014-08-06

Who can join

Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.